U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503821) titled 'Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis' on March 17.
Brief Summary: Pigmented villonodular synovitis (PVNS) is a rare joint disease caused by the proliferation of synovial tissue, leading to significant pain and joint destruction. It typically begins between the ages of 30 and 50 and significantly affects patients' functionality. The proliferation is due to somatic mutations in some fibroblastic cells within the tissue, which triggers a massive recruitment of inflammatory cells. The condition is considered a benign tumor of the synovial membrane with a major inflammatory component. Diagn...